Department of Internal Medicine, Division of Hematology, Oncology, Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA.
Am J Clin Oncol. 2020 Sep;43(9):670-675. doi: 10.1097/COC.0000000000000720.
During the course of therapy, patients with small cell lung cancer have been noted to develop transformation to non-small cell lung cancer and conversely, patients with non-small cell lung cancer have had transformation to small cell lung cancer or other non-small cell histologies. Transformation may occur after prior tyrosine kinase inhibitors, chemotherapy, immunotherapy or radiation therapy. These changes reflect on the overlapping biology of these cell types and the clinical need for re-biopsy at times of disease progression. The optimum therapy after transformation will depend upon prior therapies received, the functional capacity of the patient, and further research to define the best therapy options.
在治疗过程中,已注意到小细胞肺癌患者发生向非小细胞肺癌的转化,反之亦然,非小细胞肺癌患者发生向小细胞肺癌或其他非小细胞组织学的转化。转化可发生在先前的酪氨酸激酶抑制剂、化疗、免疫疗法或放射治疗之后。这些变化反映了这些细胞类型的生物学重叠,以及在疾病进展时重新进行活检的临床需求。转化后的最佳治疗将取决于先前接受的治疗、患者的功能能力,以及进一步研究以确定最佳治疗选择。